Skip to main content

AGC Pharma Chemicals will participate in the upcoming BIO International Convention, taking place from June 3rd to 6th in San Diego. As the largest and most comprehensive event for the biotechnology industry, the BIO International Convention is an unparalleled platform to showcase our cutting-edge solutions and engage with over 20,000 industry leaders from across the globe.

At AGC Pharma Chemicals, we are committed to driving innovation and excellence in API development and manufacturing. During the convention, we will be highlighting our advanced capabilities in process development, API life cycle management, and our broad technology portfolio, including fluorination and high-potency APIs. Our team of experts will be available to discuss how we can partner with you to bring your projects to market efficiently and effectively.

We look forward to connecting with industry peers, exploring new opportunities, and contributing to the advancement of the pharma and biotech sector.

Latest News

AGC PharmaEvents & ConventionsAGC Pharma Chemicals at CPHI Milan 2024: Let’s talk small molecule innovation
30th September 2024

AGC Pharma Chemicals at CPHI Milan 2024: Let’s talk small molecule innovation

AGC Pharma Chemicals is thrilled to announce its participation at CPHI Milan 2024, taking place from October 8-10. CPHI Milan unites industry leaders, pharma professionals and business of all sizes under…
AGC PharmaEvents & ConventionsAGC Pharma Chemicals at NLSDays 2024
10th September 2024

AGC Pharma Chemicals at NLSDays 2024

We are delighted to announce AGC Pharma Chemicals’ participation in NLSDays 2024, scheduled for September 18th to 19th in Malmö, Sweden. The largest Nordic partnering conference dedicated to the life…
AGC PharmaResources & DevelopmentCarbon Footprint and CDMOs: How is AGC Pharma Chemicals addressing it?
24th July 2024

Carbon Footprint and CDMOs: How is AGC Pharma Chemicals addressing it?

The production of medicines, while vital for human health, leaves a substantial environmental footprint. According to the Sustainable Markets Initiative (SMI), the Biopharmacy industry is responsible for 4–5% of all…